Evaluate Efficacy Levobupivacaine 0.125% Versuss Ropivacaine 0.2% in Hemodynamic Alterations in Labor and Fetal Repercussions

NCT05877131 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hemodynamic Instability
Epidural
Pregnancy
Fetal Cardiac Disorder

Interventions

DRUG: Levobupivacaine
DRUG: Ropivacaine

Sponsor

Althaia Xarxa Assistencial Universitària de Manresa